跳至主要内容

About Us: Kaifeng Darui Pharmaceutical Co., Ltd. – Elevating Global Healthcare Through Innovation

At Kaifeng Darui Pharmaceutical Co., Ltd. (Darui Pharma), we are a dynamic high-tech enterprise pioneering the development, production, and global distribution of high-end pharmaceutical intermediatesveterinary APIshuman APIs, and food additives. Nestled in the thriving chemical hub of Kaifeng, Henan Province, we harness the region’s abundant chemical resources and deep talent pool to deliver cutting-edge solutions that redefine industry standards. With a relentless focus on automation, sustainability, and innovation, we are committed to becoming a trusted partner in advancing global healthcare.

Innovation-Driven R&D: The Core of Our Success

At the heart of our success lies a world-class R&D Center dedicated to breakthroughs in pharmaceutical science. With an annual R&D investment exceeding ¥10 million, our team of 12 in-house experts—including 4 intermediate engineers2 senior engineers2 associate professors, and 1 lecturer—collaborates with 3 industry-leading PhD consultants specializing in fine chemistry. This powerhouse of young, specialized talent drives advancements in synthetic route optimizationprocess intensification, and green chemistry, enabling us to:

  • Develop high-purity intermediates and APIs like Albendazole (antiparasitic), Acyclovir (antiviral), and Bronopol (preservative).
  • Achieve rapid scale-up from lab to commercial production through advanced pilot facilities.
  • Secure proprietary technologies that position us as leaders in niche markets.

Smart Manufacturing Infrastructure: Precision Meets Scalability

To meet global demand, we’ve invested heavily in automated, intelligent production systems designed for efficiency and compliance:

  • Advanced Facilities: Fully automated synthesis reactors, precision distillation units, and isolation systems ensure batch-to-batch consistency.
  • Quality Assurance: State-of-the-art analytical labs equipped with HPLCGC-MS, and FTIR spectrometers guarantee 100% compliance with pharmacopeia standards.
  • Eco-Conscious Operations: Integrated RCO exhaust treatment and 150-ton/day wastewater recycling systems minimize environmental impact, aligning with China’s green manufacturing goals.

Sustainability in Action: Green Chemistry, Global Impact

As stewards of the planet, we embed sustainability into every facet of our operations:

  • Circular Economy: Byproduct recovery and solvent recycling programs reduce waste and resource consumption.
  • Clean Energy: Transitioning to solar-powered facilities to cut carbon emissions by 30% by 2026.
  • Community Commitment: Partnering with local universities to nurture the next generation of pharmaceutical innovators.

Our Product Portfolio & Collaboration Models

Core Offerings:

  • Pharmaceutical Intermediates: Customized intermediates for antiviral, antiparasitic, and anti-inflammatory APIs.
  • Veterinary APIs: GMP-certified active ingredients for livestock and pet medications.
  • Human APIs: High-purity compounds for oncology, neurology, and infectious disease treatments.
  • Food Additives: Safe, compliant preservatives and stabilizers for the food industry.

Flexible Partnerships:

  • CMO/CDMO Services: From lab-scale synthesis to commercial-scale production, we offer end-to-end support for complex molecules.
  • OEM Solutions: Tailored formulations and packaging for global regulatory markets (FDA, EMA, WHO-GMP).
  • Technology Transfer: Collaborate with our R&D team to co-develop proprietary processes.

Why Partner with Darui Pharma?

  • Speed to Market: Agile R&D and scalable infrastructure reduce development cycles by up to 40%.
  • Cost Efficiency: Kaifeng’s resource advantages enable competitive pricing without compromising quality.
  • Trust & Transparency: Rigorous IP protection protocols and real-time production tracking ensure peace of mind.

Join Us in Shaping the Future of Pharma
At Darui Pharma, we believe innovation thrives on collaboration. Whether you’re a startup seeking niche intermediates or a multinational corporation exploring sustainable APIs, let’s co-create solutions that transform healthcare.

Kaifeng Darui Pharmaceutical Co., Ltd.

Kaifeng Darui Pharmaceutical Co., Ltd.

Dedicated to high-end pharmaceutical raw materials, food additives, and intermediates.

About Us

Kaifeng Darui Pharmaceutical Co., Ltd., established on June 19, 2020, with a registered capital of 27 million RMB, is a high-tech enterprise located in the Kaifeng Fine Chemical Industrial Park. We focus on the R&D, production, and sales of high-end pharmaceutical raw materials, food additives, and intermediates.

We are a professional GMP-certified manufacturer of veterinary non-sterile APIs, strictly adhering to veterinary GMP requirements in design and construction. Our facility boasts a clean production environment and a rational layout.

We uphold the concept of green development, emphasizing talent and team building to achieve sustainable and healthy growth.

Financial Highlights:

  • 2023 Total Output Value: 44 million RMB, Tax Contribution: 1.45 million RMB.
  • 2024 Total Output Value: Over 60 million RMB, Tax Contribution: 2 million RMB.

Company Philosophy: "Survive by quality, root in talent; develop by technology, benefit from management." We persistently pursue excellent quality and a perfect brand and corporate image.

Research & Development

Since our inception, we established a dedicated technical team for R&D and technology introduction. Currently, we employ over 100 staff, with more than 20 R&D professionals (over 20% of workforce). Over 70% hold college degrees or higher, including 2 senior engineers, 2 associate professors, 1 lecturer, and 4 intermediate engineers.

We possess an independent R&D center (320 sq meters) with professional chemical laboratories and dedicated testing/analysis units. Our equipment includes HPLC, GC, UV-Vis Spectrophotometers, analytical balances, moisture analyzers, etc.

We collaborate closely with domestic universities and research institutions like Henan Academy of Sciences Chemical Research Institute Co., Ltd., Pingdingshan University, and Xinxiang Medical University to foster industry-university-research cooperation.

Facilities

Our plant is designed and built according to "Veterinary Drug Manufacturing Quality Management Standards".

  • Non-sterile API workshop (700 sq meters) with synthesis and refining/drying/packaging sections.
  • Two production lines with separate air purification systems; clean areas meet Class D standards.
  • Standardized production workshops, distillation equipment, 150 t/d wastewater treatment facility, and RCO exhaust gas treatment unit.
  • Water production equipment and air conditioning/purification systems.
  • Warehousing: Raw/auxiliary material, finished product, packaging material, and special management finished product warehouses.

Qualifications & Honors

  • High-tech Enterprise Certification (2023).
  • Henan Province Innovative Small and Medium-sized Enterprise (Dec 2022).
  • Kaifeng City Alkane Bromination Product Engineering Technology Research Center (2023).
  • Loving Charity Enterprise Title (Jan 2023).
  • Kaifeng Pharmaceutical Industry Association Council Member (Since 2021), Chairman Yang Xiaoke appointed as Council Director (Jan 2024).
  • Veterinary Drug Production License and 18 API GMP Certificates from Henan Provincial Department of Agriculture and Rural Affairs (Nov 2024).

Intellectual Property

We emphasize technological innovation and transformation. As of the report date, we hold 12 utility model patents, with 4 applications pending. These patents enhance our independent innovation capabilities and promote the transformation of scientific achievements.

Products & Services / Cooperation

Focus Areas:

  • Fine Chemicals & APIs
  • Food Additives
  • Fine Chemical & Pharmaceutical Intermediates

Areas for Cooperation:

  • Development of new veterinary and pet APIs.
  • Development of new food additives.
  • Cooperation on key production technologies, development and application of fine chemicals and pharmaceutical intermediates.

Future Outlook & Industry Prospects

As a certified High-tech Enterprise, we aim to standardize R&D project management, enhance innovation, and follow the growth path of quality SMEs (Sci-tech SME, Innovative SME, "Specialized, Refined, Unique, New" SME, Sci-tech Little Giant).

Key Development Directions:

  • Leveraging alkane bromination technology, establishing a national-level R&D, demonstration, training, pilot testing, and cooperation base.
  • Strengthening high-value-added biomedical fine products based on existing antiviral and anthelmintic products through R&D and university collaborations.
  • Continuing focus on veterinary APIs, capitalizing on the growing pet market, expanding livestock farming needs, and increasing international competitiveness and export opportunities for Chinese veterinary APIs.

Three-Year Goal (Targeting 2025): Achieve 100 million RMB in production and sales value, increase R&D investment to 20 million RMB, develop 2-3 new products annually, and attain the "Specialized, Refined, Unique, New" enterprise status.

© Kaifeng Darui Pharmaceutical Co., Ltd. All rights reserved.

Contact Us

Address: Kaifeng Fine Chemical Park, Henan, China

Tel: +86-13837178289

Email: [email protected]